MiR-21 and Tocilizumab interactions improve COVID-19 myocarditis outcomes

BACKGROUND: Myocarditis is now one of the most fatal and morbid complications of COVID-19. Many scientists have recently concentrated on this problem. OBJECTIVES: This study assessed the effects of Remdesivir (RMS) and Tocilizumab (TCZ) in COVID-19 myocarditis. DESIGN: Observational, cohort study. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossein Heydari, Amir, Ghaffari, Saeid, Khani, Zahra, Heydari, Sophia, Eskandari, Zakaria, Esmaeil Heidari, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333985/
https://www.ncbi.nlm.nih.gov/pubmed/37427793
http://dx.doi.org/10.1177/17539447231182548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333985/
https://www.ncbi.nlm.nih.gov/pubmed/37427793
http://dx.doi.org/10.1177/17539447231182548

Ejemplares similares